Thread by @malteseinvest

Analysis: #NASDAQ

Case 492 #Catalyst Pharmaceuticals Inc.

DISCLAIMER: The analysis is strictly for educational purposes and should not be construed as an invitation to trade.

#CPRX 1/5

Chart 1
Weekly Chart: Price is being held down by the #SMA 200 and is about to run into 2016 trendline #support at 2.74 with good buying interest at 2.38/19. Below the Mar. 2017 #pivot at 1.95 and farther down synthetic sloping at 1.50 with control at 1.47. To .....

CPRX 2/5

..... the upside, notable #resistance seen at the #Fib .50 at 4.13 (bottom of May-July range) then Sept. 2019 #trendline resistance at 4.44. Sales and profit taking has been consistent and constant into 5.06/19 and higher up the #confluence of .....

CPRX 3/5

..... synthetic #resistance and control at 5.90 colliding in Apr. 2021. A close/hold above targets the balance point at 7.26.

CPRX 4/5

Chart 2
Daily Chart: The SMA 200 is touching Fib. 50. Watch closely 2.75/57 to initiate the position.

The #Strategy is printed on the image.

5/5